pembrolizumab
merck
['melanoma', 'congrat', 'checkpoint therap']
exciting data #esmo22, neoadjuvant immune checkpoint therapy in melanoma. congrats &amp; team! true validation of work by in 2006 to develop the first neoadjuvant immune checkpoint trial, providing critical safety data to advance the field. #endcancer
Husband to @PamSharmaMDPhD, Chair of Immunology, @MDAndersonNews, 2018 Nobel Laureate in Medicine, Harmonica Player, Founder @TentAbrahams